Use of Artificial Intelligence in Molecular Pharmacology

dc.contributor.authorAmarjot Kaur Grewal
dc.date.accessioned2025-12-19T09:36:59Z
dc.date.available2025-12-19T09:36:59Z
dc.date.issued2024-04-20
dc.description.abstractOver the last few years, artificial intelligence (AI) has emerged as a robust force in biomedical research, and especially in drug development—an inherently complex but fundamentally important area, where efficiency and effectiveness have been major barriers in the past. With the transformational capabilities in molecular pharmacology, AI is helping revolutionize research by offering molecular pharmacology on virtual screening of chemical libraries, de novo drug design, molecular interactions, prediction of pharmacokinetic properties, prediction of drug target interactions, prediction of toxicities, patient stratification, clinical trial optimization, improved molecular structures, and potential side effects. These algorithms can help cascade the identification of lead compounds and optimization of the therapeutic candidate through the drug development process. Using traditional methods, it is difficult to identify the complex interplay of molecules and pathways in diseases. Making drug development more efficient and cost-effective, traditional pharmacological approaches are transforming to the use of AI algorithms for analyzing massive biological datasets and modeling complex biological systems like genomics and proteomics to identify disease-associated targets and predict interaction with potential drug candidates using network analysis tools and graph neural networks. Gene expression changes in diseased cells can be analyzed using AI in identifying novel drug targets and identifying the critical pathways for intervention.
dc.identifier.issn2321-2217
dc.identifier.issn2321-2225
dc.identifier.otherhttps://doi.org/10.15415/jprtm.2024.121008
dc.identifier.urihttps://demodspace.chitkara.edu.in/handle/123456789/297
dc.language.isoen
dc.publisherChitkara University Publications
dc.subjectArtificial Intelligence (AI) in Drug Discovery
dc.subjectMolecular pharmacology
dc.subjectMachine learning
dc.subjectDeep learning
dc.subjectPredictive modeling
dc.subjectPersonalized medicine
dc.titleUse of Artificial Intelligence in Molecular Pharmacology
dc.typeArticle

Files

Original bundle
Now showing 1 - 1 of 1
No Thumbnail Available
Name:
JPTRM Volume 12 Issue 1 008.pdf
Size:
294.49 KB
Format:
Adobe Portable Document Format
License bundle
Now showing 1 - 1 of 1
No Thumbnail Available
Name:
license.txt
Size:
1.71 KB
Format:
Item-specific license agreed to upon submission
Description: